Ajanta Pharma is trading lower by 4% at Rs 986, falling over 11% from intra-day’s high, after recommending a bonus shares in the ratio of one new fully paid-up equity share for every two fully paid-up equity share.
Meanwhile, the pharmaceutical company has reported a robust 66% year-on-year (yoy) jumped in its net profit at Rs 33 crore on back of 26% yoy growth in operational revenues at Rs 219 crore for the quarter ended June 30, 2013 (Q1).
The stock opened at Rs 1,021 and hit a high of Rs 1,110 on BSE, before the announcements of bonus shares and Q1 earnings. A combined 331,362 shares have changed hands on the counter till 1118 hours on BSE and NSE.
Meanwhile, the pharmaceutical company has reported a robust 66% year-on-year (yoy) jumped in its net profit at Rs 33 crore on back of 26% yoy growth in operational revenues at Rs 219 crore for the quarter ended June 30, 2013 (Q1).
The stock opened at Rs 1,021 and hit a high of Rs 1,110 on BSE, before the announcements of bonus shares and Q1 earnings. A combined 331,362 shares have changed hands on the counter till 1118 hours on BSE and NSE.
